https://www.thebodypro.com/author/canadian-aids-treatment-information-exchange

Latest by Canadian AIDS Treatment Information Exchange

Research Finds That Harm Reduction and ART Helped to Reduce the Spread of HIV in Vancouver Img
People Who Use Drugs

Research Finds That Harm Reduction and ART Helped to Reduce the Spread of HIV in Vancouver

Researchers at the British Columbia Centre for Excellence in HIV/AIDS along with other researchers in Vancouver have attempted to study the relative impact that ART, harm reduction or both can have on the spread of HIV.

A Nurse-Led Adherence Intervention for HIV Works and Saves Money Img

A Nurse-Led Adherence Intervention for HIV Works and Saves Money

A study has shown that a nurse-led intervention called AIMS (Adherence Improving self-Management Strategy) has had a measurable and significant effect on improving treatment success rates.

Bictegravir -- An Emerging Integrase Inhibitor Img
CROI (Conference on Retroviruses and Opportunistic Infections)

Bictegravir -- An Emerging Integrase Inhibitor

Bictegravir-containing regimens performed well over 48 weeks, with more than 90% of participants achieving a viral load less than 50 copies/mL.

A New Nuke in the Works -- GS-9131 Img
CROI (Conference on Retroviruses and Opportunistic Infections)

A New Nuke in the Works -- GS-9131

The new nucleoside analogue GS-9131 may be useful as part of regimens for people who have strains of drug-resistant HIV.

Doravirine versus Darunavir Img
CROI (Conference on Retroviruses and Opportunistic Infections)

Doravirine versus Darunavir

A recent clinical trial found that doravirine was roughly equivalent in potency to darunavir-based regimens.

New Drugs, New Hope and Possible Timelines Img
CROI (Conference on Retroviruses and Opportunistic Infections)

New Drugs, New Hope and Possible Timelines

At the recent Conference on Retroviruses and Opportunistic Infections, researchers presented data about 5 new anti-HIV compounds in development.

The Capsid Inhibitor -- A New Class to Enter Clinical Trials Img
CROI (Conference on Retroviruses and Opportunistic Infections)

The Capsid Inhibitor -- A New Class to Enter Clinical Trials

A capsid inhibitor could affect three parts of HIV's life cycle and could be used by itself in the prevention of HIV infection. However, much work lies ahead before this drug's developer can be certain about that.

Do Integrase Inhibitors Affect Testosterone Levels in Men? Img
Endocrine/Sexual Dysfunction

Do Integrase Inhibitors Affect Testosterone Levels in Men?

In a small cross-sectional study researchers found a link between the use of integrase inhibitors and the presence of low testosterone, but they may have inadvertently arrived at this conclusion.